AstraZeneca Rhythm Acquisition: Smart Move for Rare Obesity

AstraZeneca Rhythm Acquisition: Smart Move for Rare Obesity

AstraZeneca Rhythm acquisition targets rare obesity market, promising significant advancements in treatment options.
read more

HUTCHMED lung cancer drug: Proven Approval Process

HUTCHMED lung cancer drug seeks FDA approval with AstraZeneca's filing.
read more